Literature DB >> 28189905

New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates.

Mohammad Eghtedari1, Yaghoub Sarrafi2, Hamid Nadri3, Mohammad Mahdavi4, Alireza Moradi3, Farshad Homayouni Moghadam5, Saeed Emami6, Loghman Firoozpour4, Ali Asadipour7, Omid Sabzevari8, Alireza Foroumadi9.   

Abstract

A series of poly-functionalized tacrine-derived compounds namely 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates were designed and synthesized as cholinesterases inhibitors. The in vitro inhibition assay against AChE and BuChE demonstrated that most of compounds had potent AChE inhibitory with reserving potential of BuChE inhibition. Among them, compound 6i bearing a 4-(3-bromophenyl) moiety showed the most potent activity against AChE/BuChE (IC50s values of 0.069 and 1.35 μM, respectively). The anti-AChE activity of 6i was five times more than that of tacrine. The SAR study revealed that chloro/bromo substituent at ortho or meta position of the 4-phenyl ring can improve the anticholinesterase activity.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Tacrine

Mesh:

Substances:

Year:  2017        PMID: 28189905     DOI: 10.1016/j.ejmech.2017.01.042

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Synthesis and anticholinesterase activity of novel non-hepatotoxic naphthyridine-11-amine derivatives.

Authors:  Belma Zengin Kurt
Journal:  Mol Divers       Date:  2018-12-04       Impact factor: 2.943

Review 2.  Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.

Authors:  Rami J Obaid; Nafeesa Naeem; Ehsan Ullah Mughal; Munirah M Al-Rooqi; Amina Sadiq; Rabab S Jassas; Ziad Moussa; Saleh A Ahmed
Journal:  RSC Adv       Date:  2022-07-12       Impact factor: 4.036

Review 3.  Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity.

Authors:  Todd J Eckroat; Danielle L Manross; Seth C Cowan
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

4.  Late-Stage Modification of Medicine: Pd-Catalyzed Direct Synthesis and Biological Evaluation of N-Aryltacrine Derivatives.

Authors:  Lin-Xi Wan; Yong-Qi Zhen; Zhen-Xiang He; Yang Zhang; Lan Zhang; Xiaohuan Li; Feng Gao; Xian-Li Zhou
Journal:  ACS Omega       Date:  2021-04-02

5.  Design, synthesis and biological evaluation of novel N-phosphorylated and O-phosphorylated tacrine derivatives as potential drugs against Alzheimer's disease.

Authors:  Maja Przybyłowska; Krystyna Dzierzbicka; Szymon Kowalski; Sebastian Demkowicz; Mateusz Daśko; Iwona Inkielewicz-Stepniak
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

6.  Cu-metal organic frameworks (Cu-MOF) as an environment-friendly and economical catalyst for one pot synthesis of tacrine derivatives.

Authors:  Hoda Mollabagher; Salman Taheri; Mohammad Majid Mojtahedi; SeyedAmirhossein Seyedmousavi
Journal:  RSC Adv       Date:  2020-01-09       Impact factor: 4.036

Review 7.  Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential.

Authors:  Saikat Mitra; Maniza Muni; Nusrat Jahan Shawon; Rajib Das; Talha Bin Emran; Rohit Sharma; Deepak Chandran; Fahadul Islam; Md Jamal Hossain; Sher Zaman Safi; Sherouk Hussein Sweilam
Journal:  Oxid Med Cell Longev       Date:  2022-08-18       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.